Reply by Authors

Affiliations

¹ Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
² Institute of Urology, University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California.
³ Carolina Urologic Research Center, Myrtle Beach, South Carolina.
⁴ Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
⁶ Department of Urology, DuPage Medical Group, Chicago, Illinois.
⁷ Pacific Edge Ltd, Dunedin, New Zealand.
⁸ Pacific Edge Diagnostics, Redwood City, California.
⁹ Department of Urology, Penn State Health, Hershey, Pennsylvania.

Comment

Yair Lotan et al. J Urol. 2024 Jul.

. 2024 Jul;212(1):50-51.

doi: 10.1097/JU.0000000000004028. Epub 2024 May 10.

¹ Department of Urology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas.
² Institute of Urology, University of Southern California/Norris Comprehensive Cancer Center Los Angeles, California.
³ Carolina Urologic Research Center, Myrtle Beach, South Carolina.
⁴ Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
⁵ Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
⁶ Department of Urology, DuPage Medical Group, Chicago, Illinois.
⁷ Pacific Edge Ltd, Dunedin, New Zealand.
⁸ Pacific Edge Diagnostics, Redwood City, California.
⁹ Department of Urology, Penn State Health, Hershey, Pennsylvania.

No abstract available

Comment on

Editorial Comment.
Matulewicz RS. Matulewicz RS. J Urol. 2024 Jul;212(1):49-50. doi: 10.1097/JU.0000000000004005. Epub 2024 May 3. J Urol. 2024. PMID: 38701227 No abstract available.
Editorial Comment.
Richards KA. Richards KA. J Urol. 2024 Jul;212(1):49. doi: 10.1097/JU.0000000000004004. Epub 2024 May 7. J Urol. 2024. PMID: 38713580 No abstract available.